BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 22128088)

  • 1. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
    Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
    Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart.
    Belke DD
    J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation.
    Dassanayaka S; Brittian KR; Jurkovic A; Higgins LA; Audam TN; Long BW; Harrison LT; Militello G; Riggs DW; Chitre MG; Uchida S; Muthusamy S; Gumpert AM; Jones SP
    Basic Res Cardiol; 2019 May; 114(4):28. PubMed ID: 31152247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
    Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
    Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective O-GlcNAc signaling is elevated in murine female hearts via enhanced O-GlcNAc transferase activity.
    Narayanan B; Sinha P; Henry R; Reeves RA; Paolocci N; Kohr MJ; Zachara NE
    J Biol Chem; 2023 Dec; 299(12):105447. PubMed ID: 37949223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of O-GlcNAcylation is important for pig preimplantation development.
    Shibutani M; Mori T; Miyano T; Miyake M
    J Reprod Dev; 2015; 61(4):341-50. PubMed ID: 26004176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAc Transferase Promotes Compensated Cardiac Function and Protein Kinase A O-GlcNAcylation During Early and Established Pathological Hypertrophy From Pressure Overload.
    Zhu WZ; El-Nachef D; Yang X; Ledee D; Olson AK
    J Am Heart Assoc; 2019 Jun; 8(11):e011260. PubMed ID: 31131693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessive
    Umapathi P; Mesubi OO; Banerjee PS; Abrol N; Wang Q; Luczak ED; Wu Y; Granger JM; Wei AC; Reyes Gaido OE; Florea L; Talbot CC; Hart GW; Zachara NE; Anderson ME
    Circulation; 2021 Apr; 143(17):1687-1703. PubMed ID: 33593071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UDP-N-acetylglucosamine transferase and glutamine: fructose 6-phosphate amidotransferase activities in insulin-sensitive tissues.
    Yki-Järvinen H; Vogt C; Iozzo P; Pipek R; Daniels MC; Virkamäki A; Mäkimattila S; Mandarino L; DeFronzo RA; McClain D; Gottschalk WK
    Diabetologia; 1997 Jan; 40(1):76-81. PubMed ID: 9028721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocyte Oga haploinsufficiency increases O-GlcNAcylation but hastens ventricular dysfunction following myocardial infarction.
    Dassanayaka S; Brittian KR; Long BW; Higgins LA; Bradley JA; Audam TN; Jurkovic A; Gumpert AM; Harrison LT; Hartyánszky I; Perge P; Merkely B; Radovits T; Hanover JA; Jones SP
    PLoS One; 2020; 15(11):e0242250. PubMed ID: 33253217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
    Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
    PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
    Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH
    Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of a compensatory regulation of colonic O-GlcNAc transferase and O-GlcNAcase expression in response to disruption of O-GlcNAc homeostasis.
    Decourcelle A; Loison I; Baldini S; Leprince D; Dehennaut V
    Biochem Biophys Res Commun; 2020 Jan; 521(1):125-130. PubMed ID: 31630803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-539 is up-regulated in failing heart, and suppresses O-GlcNAcase expression.
    Muthusamy S; DeMartino AM; Watson LJ; Brittian KR; Zafir A; Dassanayaka S; Hong KU; Jones SP
    J Biol Chem; 2014 Oct; 289(43):29665-76. PubMed ID: 25183011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain.
    Liu Y; Li X; Yu Y; Shi J; Liang Z; Run X; Li Y; Dai CL; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
    PLoS One; 2012; 7(8):e43724. PubMed ID: 22928023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained
    Tan EP; McGreal SR; Graw S; Tessman R; Koppel SJ; Dhakal P; Zhang Z; Machacek M; Zachara NE; Koestler DC; Peterson KR; Thyfault JP; Swerdlow RH; Krishnamurthy P; DiTacchio L; Apte U; Slawson C
    J Biol Chem; 2017 Sep; 292(36):14940-14962. PubMed ID: 28739801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired vasodilator activity in deoxycorticosterone acetate-salt hypertension is associated with increased protein O-GlcNAcylation.
    Lima VV; Giachini FR; Choi H; Carneiro FS; Carneiro ZN; Fortes ZB; Carvalho MH; Webb RC; Tostes RC
    Hypertension; 2009 Feb; 53(2):166-74. PubMed ID: 19139380
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Silva-Aguiar RP; Bezerra NCF; Lucena MC; Sirtoli GM; Sudo RT; Zapata-Sudo G; Takiya CM; Pinheiro AAS; Dias WB; Caruso-Neves C
    J Biol Chem; 2018 Aug; 293(33):12749-12758. PubMed ID: 29954945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yeast cells as an assay system for in vivo O-GlcNAc modification.
    Nakanishi H; Li F; Han B; Arai S; Gao XD
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.